EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
63.50
-1.00 (-1.55%)
At close: Aug 10, 2026
0.79% (1Y)
| Market Cap | 113.86M +1.2% |
| Revenue (ttm) | 9.54M -1.8% |
| Net Income | 2.83M +118.1% |
| EPS | 1.59 +119.8% |
| Shares Out | 1.79M |
| PE Ratio | 39.98 |
| Forward PE | n/a |
| Dividend | 2.00 (3.15%) |
| Ex-Dividend Date | Jun 18, 2026 |
| Volume | 7 |
| Open | 63.50 |
| Previous Close | 64.50 |
| Day's Range | 63.50 - 63.50 |
| 52-Week Range | 59.00 - 65.50 |
| Beta | 0.00 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 21, 2026 |